Review: Pharmacokinetics of illicit drugs in oral fluid

被引:125
作者
Drummer, OH
机构
[1] Monash Univ, Victorian Inst Forens Med, Melbourne, Vic 3006, Australia
[2] Monash Univ, Dept Forens Med, Melbourne, Vic 3006, Australia
关键词
pharmacokinetics; oral fluid; drugs of abuse; review;
D O I
10.1016/j.forsciint.2004.11.022
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
This article reviews studies that have measured drug concentrations in oral fluid following controlled dosing regimens. A total of 23 studies have been identified over the last 15 years. These show that the amphetamines including designer amphetamines, cocaine, cannabis and cocaine are quickly found in oral fluid following dosing and usually have similar time-courses to that in plasma. Following common doses peak oral fluid concentrations exceed 0.1 mu g/mL and often even 1 mu g/mL. The drug concentration will depend on whether a dilution step occurs with buffer as part of the sampling procedure. The uses of collectors that stimulate oral fluid usually reduce the drug concentration compared to a non-stimulated manner. This reduction will not disadvantage the recipient since it will potentially reduce the detectablity of drug in oral fluid compared to non-stimulated collections. Only one recent study has been reported for a benzodiazepine. This showed nanograrn per milliliter concentrations for flunitrazepam. More studies are required for benzodiazepines and indeed for other drugs, particularly in multiple drug situations and where disease may affect the pharmacokinetics of drugs. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:133 / 142
页数:10
相关论文
共 40 条
[1]   Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart® opiate microplate EIA and GC-MS following controlled codeine administration [J].
Barnes, AJ ;
Kim, I ;
Schepers, R ;
Moolchan, ET ;
Wilson, L ;
Cooper, G ;
Reid, C ;
Hand, C ;
Huestis, MA .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2003, 27 (07) :402-406
[2]   Effects of obesity on pharmacokinetics - Implications for drug therapy [J].
Cheymol, G .
CLINICAL PHARMACOKINETICS, 2000, 39 (03) :215-231
[3]  
CONE EJ, 1990, J ANAL TOXICOL, V14, P1
[4]   Oral fluid testing for drugs of abuse:: Positive prevalence rates by Intercept™ immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations [J].
Cone, EJ ;
Presley, L ;
Lehrer, M ;
Seiter, W ;
Smith, M ;
Kardos, KW ;
Fritch, D ;
Salamone, S ;
Niedbala, RS .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2002, 26 (08) :541-546
[5]   SALIVA TESTING FOR DRUGS OF ABUSE [J].
CONE, EJ .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 694 :91-127
[6]  
CONE EJ, 1994, CLIN CHEM, V40, P1299
[7]  
COOK CE, 1993, DRUG METAB DISPOS, V21, P717
[8]  
COOK CE, 1992, DRUG METAB DISPOS, V20, P856
[9]   Relationship of Δ9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis [J].
Huestis, MA ;
Cone, EJ .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2004, 28 (06) :394-399
[10]   COMPARISON OF HEROIN AND COCAINE CONCENTRATIONS IN SALIVA WITH CONCENTRATIONS IN BLOOD AND PLASMA [J].
JENKINS, AJ ;
OYLER, JM ;
CONE, EJ .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1995, 19 (06) :359-374